IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Pharmaceutical
Sub Sector: marketing & distribution of finished formulations of Specialty pharmaceuticals
Exchange:
BSE
Emerge
Speciality Medicines is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. Having cultivated strong and dependable customer relationships in Specialty pharmaceuticals, they have, through their distributions, established good repo with our customers spreading across more than 20 states of India and more than 35 countries all over the worlds. Speciality Medicines mission is to enhance patient care by supplying high-quality, innovative medicines that address unmet medical needs. With a strong commitment to excellence, they aim to make a positive impact on the lives of patients worldwide. Speciality Medicines is majorly engrossed in the Specialty pharmaceuticals business involving marketing, trading and distribution of wide range of Specialty pharmaceuticals finished formulations and products. Depending upon business requirements, we procured the products from existing manufacturers based in India. The Company is having Loan License Nos. G/25A/5726- A and G/28A/7020-A whereby their Company can manufacture, under own name, few products by using the manufacturing facilities of Uniza Lifecare Private Limited situated at Sr. No. 919/7, (Old Sr. No. 404), Kadi – Detroj Road, Balasar, Tal: Kadi, Dist. – Mahesana, Gujarat – 382 715. The said units of Uniza Lifecare Private Limited are approved as per WHO - GMP and other international approvals to cater to different market in India and overseas. Speciality Medicines have our presence through registered and/or Under Preparation for Registration products in countries namely Bolivia, Jordan, Ethiopia, Uganda, Peru, Philippines, Namibia, Shri Lanka and Mexico. Speciality Medicines deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet. We offer a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, neurology, and rare diseases. Speciality Medicines products are designed to meet the complex needs of patients with chronic conditions, providing innovative solutions that improve health outcomes
Skyline Financial Services Private Limited
Speciality Medicines operates in Pharmaceutical and marketing & distribution of finished formulations of Specialty pharmaceuticals. The Issue would be listed on SME. The registrar of the Issue is Skyline Financial Services Private Limited. The IPO type of Speciality Medicines is Book Building Process and Object of issue is
Merchant Banker of Speciality Medicines IPO is Ekadrisht Capital Private Limited
The DRHP (Draft Red Herring Prospectus) of Speciality Medicines IPO was filed on 14 Aug 2024.
No, Speciality Medicines IPO is not yet listed. See other upcoming SME IPOs here.
The IPO open date and IPO close date of Speciality Medicines are not available now. You can apply in Speciality Medicines IPO online using either UPI or ASBA as a payment method. ASBA IPO application can be done through net banking of your bank account. UPI IPO application is also offered by brokers, though they don't handle any banking services.
Why Us?
